QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 18, Issue 6, 2367-2377, June 2007

This Article Full Text Full Text (PDF) All Versions of this Article: E06-09-0844v1 18/6/2367    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kannemeier, C. Articles by Sun, P. Search for Related Content PubMed PubMed Citation Articles by Kannemeier, C. Articles by Sun, P.

The RING Finger Domain of MDM2 Is Essential for MDM2-mediated TGF- Resistance

Department of Molecular Biology, MB-41, The Scripps Research Institute, La Jolla, CA 92037

Submitted September 21, 2006; Revised March 26, 2007; Accepted April 2, 2007
Monitoring Editor: Gerard Evan

In this study, we attempt to gain insights into the molecular mechanism underlying MDM2-mediated TGF- resistance. MDM2 renders cells refractory to TGF- by overcoming a TGF-–induced G1 cell cycle arrest. Because the TGF- resistant phenotype is reversible upon removal of MDM2, MDM2 likely confers TGF- resistance by directly targeting the cellular machinery involved in the growth inhibition by TGF-. Investigation of the structure-function relationship of MDM2 reveals three elements essential for MDM2 to confer TGF- resistance in both mink lung epithelial cells and human mammary epithelial cells. One of these elements is the C-terminal half of the p53-binding domain, which at least partially retained p53-binding and inhibitory activity. Second, the ability of MDM2 to mediate TGF- resistance is disrupted by mutation of the nuclear localization signal, but is restored upon coexpression of MDMX. Finally, mutations of the zinc coordination residues of the RING finger domain abrogates TGF- resistance, but not the ability of MDM2 to inhibit p53 activity or to bind MDMX. These data suggest that RING finger-mediated p53 inhibition and MDMX interaction are not sufficient to cause TGF- resistance and imply a crucial role of the E3 ubiquitin ligase activity of this domain in MDM2-mediated TGF- resistance.

Address correspondence to: Peiqing Sun (pqsun{at}scripps.edu)

This article has been cited by other articles:

				M. Maguire, P. C. Nield, T. Devling, R. E. Jenkins, B. K. Park, R. Polanski, N. Vlatkovic, and M. T. Boyd MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination Cancer Res., May 1, 2008; 68(9): 3232 - 3242. [Abstract] [Full Text] [PDF]